FDA Trader

Overall Rating

Rating: 2.2/5. From 12 votes.
Please wait...
2.3
Rating from 34 votes
If you’ve subscribed to FDA Trader, please click the stars below to indicate your rating for this newsletter, and please share any other feedback about your experience using the comment box below.

Investment Performance

Rating from 8 votes
Rating: 2.4/5. From 8 votes.
Please wait...
Your vote
  • 5 Stars 0 Votes
  • 4 Stars 1 Votes
  • 3 Stars 3 Votes
  • 2 Stars 2 Votes
  • 1 Stars 2 Votes

Quality Of Writing/Analysis

Rating from 8 votes
Rating: 2.6/5. From 8 votes.
Please wait...
Your vote
  • 5 Stars 1 Votes
  • 4 Stars 1 Votes
  • 3 Stars 2 Votes
  • 2 Stars 2 Votes
  • 1 Stars 2 Votes

Value For Price

Rating from 6 votes
Rating: 2.2/5. From 6 votes.
Please wait...
Your vote
  • 5 Stars 0 Votes
  • 4 Stars 0 Votes
  • 3 Stars 3 Votes
  • 2 Stars 1 Votes
  • 1 Stars 2 Votes

Customer Service

Rating from 12 votes
Rating: 2.2/5. From 12 votes.
Please wait...
Your vote
  • 5 Stars 0 Votes
  • 4 Stars 2 Votes
  • 3 Stars 2 Votes
  • 2 Stars 4 Votes
  • 1 Stars 4 Votes

Share your thoughts...

9 Comments on "FDA Trader"

Notify of
avatar

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Ljw
Guest
0

In 2 months lost $18,000. With his advice

thecasualobserver
Member
2
Joined the service when it was launched. I spend a lot of time with the FDA trader recommendations. But it has payed off. I am pretty close to doubling my money in march of 2014 (started with 5K now nearly 10K). The service works for you BUT you have to work with it. Mampilly’s hysterical style was hard to take and I was glad when he an Agora parted company. But I did learn something during that brief time. The whole medical development space is the ‘buy the rumor, sell the news’ sector on steroids. The nice thing is that… Read more »
Add a Topic
3022
Add a Topic
6137
Add a Topic
3496
vipulsea
Irregular
8
It seems that folks are in the need to make immediate winners as soon as a stock is touted by a newsletter. I subscribed to the FDA Trader and bought four of the recommended stocks when the newsletter came out. In a period of less than 6 months I have had winners from all the picks – KYTH + 57%; IMGN + 58%, RVNC +63%; INCY +93% This is a pretty good track record, and so I believe folks need to give time for the picks to work out and given that we are in a very bullish biotech market,… Read more »
Add a Topic
5974
denap007
Member
1
Agreed. All losses except GILD,CELG, and BMY and I don’t need somebody to pick blue chip leaders for me. Anybody can see these are long term holds. DTRX was way up and should have sold but he says to hold then it crashes. Could have made almost $3k on that one ended up losing $700. Today he wants his subscribers to buy TKMR and BCRX because he believes Ebola is going to spread across the U.S. Yesterday he said don’t buy wait for the hype to settle down. Whatever I think he is throwing darts at dart board with ticker… Read more »
Add a Topic
4282
jsg123
Member
0

Nothing but losses.

clinambrogio
Member
1

Lots of talk but very little action. The author keeps saying that he will make money for his subscribers. I’m beginning to doubt I will only loose money after I pay the high fee for the service. Avoid!

Add a Topic
372
clinambrogio
Member
1

I have been in this service since its start. The author keeps making promises of excessive returns when a new drug takes off. So far, 4 months, there has been no explosion even after his advertised date of a great takeoff for the stock. Some stocks have dropped considerably and in the past 2 weeks many have fallen. Lots of talk but not much action.

Add a Topic
5971
JDV1956
Guest
0

Author is biased toward shorts of his reco’s, that is the only logical conclusion I can make. Have been with service since inception, and everytime he makes a reco, the stock drops large!

Add a Topic
5971
wpDiscuz